NCT05276128 is a NA clinical trial of lipids in Diabete Type 2, sponsored by Lund University.

Who is sponsoring NCT05276128?

NCT05276128 is sponsored by Lund University.

What drugs are being tested in NCT05276128?

Interventions in NCT05276128: lipids.

What condition does NCT05276128 study?

NCT05276128 studies Diabete Type 2, Obesity.

Is NCT05276128 still recruiting?

NCT05276128 is currently completed. Last updated 28 April 2022.

Last reviewed 2022-04-28 · How we verify

NCT05276128

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Plant Based Lipids on Glucose Regulation and Cognitive Variables

Completed NA Last updated 28 April 2022

What this trial tests

NA trial testing lipids in Diabete Type 2 in 17 participants. Completed in 27 April 2022.

Timeline

20 March 2022

Primary endpoint
27 April 2022

27 April 2022

Quick facts

Lead sponsor	Lund University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	prevention
Enrollment	17
Start date	20 March 2022
Primary completion	27 April 2022
Estimated completion	27 April 2022
Sites	2 locations across Sweden

Drugs / interventions tested

lipids — full drug profile →

Conditions studied

Diabete Type 2 — all drugs for Diabete Type 2 →
Obesity — all drugs for Obesity →

Sponsor

Lund University

Who can join

Adults 20 to 40, any sex, with Diabete Type 2 or Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The overall goal is to increase the knowledge that can be used for the development of food products with anti-diabetic properties, with the purpose to facilitate healthier food choices for people. More specifically the primary purpose of this project is to evaluate effects in healthy humans on acute postprandial glucose regulation of plant based lipids. Due to the tight connection between cardiometabolic health and cognitive functions, a secondary issue is to investigate effects of test foods on cognitive test variables and mood parameters.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Diabete Type 2

Currently open trials in the same condition.

NCT07506356 — Investigation of Gastric Emptying by Gastric Ultrasonography in Diabetic Patients Treated With GLP-1 Receptors · recruiting
NCT07467460 — Precision Medicine and Neurodegenerative Diseases: Advanced Systems for the Diagnosis and Treatment of Parkinson's Disea · recruiting
NCT07469943 — The Effect of Sodium Glucose Co-trnasportert Type 2 Inhibitors on Arterial Stiffness, Endothelial Glycocalyx Thickness a · recruiting
NCT07495787 — Magnetic Compression Anastomosis Procedure for Partial Jejunoileal Anastomosis: Assessing the Viability of an Innovative · NA · recruiting
NCT07212075 — Precision Subclassification of Mental Health in Diabetes: Digital Twins for Precision Mental Health to Track Subgroups · recruiting

Other Lund University trials

Trials by the same sponsor.

NCT06661460 — Internet-Delivered Cognitive Behavioral Intervention for Youths With Anxiety Disorders · NA · recruiting
NCT07425925 — Digital Peer-support-based Anti-HIV Stigma Intervention Among Adolescents Living With HIV in Ethiopia · NA · recruiting
NCT07407842 — UPSIDES - Recovery Through Peer Support · NA · enrolling by invitation
NCT07141108 — Self-monitoring and Remote Monitoring of Chronic Pain in Primary Care - Using a Digital Tool to Improve Quality of Life · NA · recruiting
NCT07025694 — Exercise Training Among Children With Cerebral Palsy to Increase Health and Well-being - A Feasibility Study · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05276128 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Lund University
Last refreshed: 28 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05276128.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing